Chemical angioplasty with spasmolytics for vasospasm after subarachnoid hemorrhage
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F17%3A00066941" target="_blank" >RIV/00159816:_____/17:00066941 - isvavai.cz</a>
Alternative codes found
RIV/44555601:13440/17:43888410 RIV/44555601:13450/17:43893449 RIV/00216208:11110/17:10362250 RIV/00216208:11140/17:10362250 and 2 more
Result on the web
<a href="http://dx.doi.org/10.1007/s00701-017-3104-5" target="_blank" >http://dx.doi.org/10.1007/s00701-017-3104-5</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s00701-017-3104-5" target="_blank" >10.1007/s00701-017-3104-5</a>
Alternative languages
Result language
angličtina
Original language name
Chemical angioplasty with spasmolytics for vasospasm after subarachnoid hemorrhage
Original language description
Background Clinically symptomatic vasospasm leading to delayed ischemic neurological deficits occurs in up to 30% of patients with subarachnoid hemorrhage (SAH). Vasospasm can result in a serious decline in clinical conditions of patients with SAH, yet the algorithm for vasospasm treatment and prevention remains unclear. Intra-arterial administration of vasodilators is one of the modalities used for vasospasm therapy. Methods Over the last 7 years, we have treated 27 female and 7 male patients with vasospasm using intra-arterial administration of either nimodipine or milrinone; all had suffered aneurysm rupture. Of these patients, 28 were treated surgically (clip), and 6 patients had their aneurysm coiled. Spasmolytics were applied from day 2 to day 18 after rupture. Results Of the 53 procedures, angiographic improvement was documented in 92% of cases with a mean flow velocity decrease of 65 cm/s. Brain metabolism changes were monitored after the procedure. The highest level of immediate clinical improvement was observed in conscious patients with a focal neurological deficit (aphasia, hemiparesis). Overall clinical outcomes (Glasgow outcome scale, GOS) were as follows: GOS 5 (12 patients), GOS 4 (5 patients), GOS 3 (5 patients), GOS 2 (6 patients), and GOS 1 (6 patients). Conclusions Intra-arterial administration of spasmolytics is a safe and potent method of vasospasm treatment. It is most effective when applied to conscious patients with a focal deficit. For unconscious patients, its therapeutic benefits are inconclusive. Patients in severe clinical states would further require use of other diagnostic tools such as multimodal brain monitoring to complement vasospasm therapy.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30103 - Neurosciences (including psychophysiology)
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Acta Neurochirurgica
ISSN
0001-6268
e-ISSN
—
Volume of the periodical
159
Issue of the periodical within the volume
4
Country of publishing house
AT - AUSTRIA
Number of pages
8
Pages from-to
713-720
UT code for WoS article
000398164500018
EID of the result in the Scopus database
—